|
SOCS5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.68339999999856E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.184300E-04 |
| Normal-vs-Stage2 |
2.136800E-03 |
| Normal-vs-Stage3 |
1.425040E-04 |
| Normal-vs-Stage4 |
4.21120000000386E-05 |
| Stage1-vs-Stage2 |
7.078000E-01 |
| Stage1-vs-Stage3 |
5.211400E-01 |
| Stage1-vs-Stage4 |
2.299200E-01 |
| Stage2-vs-Stage3 |
9.316800E-01 |
| Stage2-vs-Stage4 |
5.200400E-01 |
| Stage3-vs-Stage4 |
5.065000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.58931999999501E-05 |
| Normal-vs-AfricanAmerican |
1.624810E-01 |
| Normal-vs-Asian |
1.647750E-02 |
| Caucasian-vs-AfricanAmerican |
1.403420E-01 |
| Caucasian-vs-Asian |
2.380800E-01 |
| AfricanAmerican-vs-Asian |
6.109200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.02500000000749E-05 |
| Normal-vs-Female |
1.025410E-04 |
| Male-vs-Female |
4.254200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.999000E-04 |
| Normal-vs-Age(41-60Yrs) |
1.622410E-04 |
| Normal-vs-Age(61-80Yrs) |
3.44630000004287E-06 |
| Normal-vs-Age(81-100Yrs) |
7.290200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.542800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.084850E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.541400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.599200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.972200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.681600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.064500E-02 |
| Classical-VS-Follicular |
1.263680E-03 |
| Classical-VS-Other |
1.159030E-01 |
| Classical-VS-Normal |
2.519500E-03 |
| Tall-VS-Follicular |
8.199600E-01 |
| Tall-VS-Other |
4.902800E-01 |
| Tall-VS-Normal |
2.356000E-04 |
| Follicular-VS-Other |
6.407800E-01 |
| Follicular-VS-Normal |
2.03300000001239E-06 |
| Other-VS-Normal |
8.760600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.79889999996075E-06 |
| Normal-vs-N1 |
2.47660000000094E-05 |
| N0-vs-N1 |
5.993600E-01 |
|
|
